Skip to main content

FDA recall, , Moderate risk

Fujirebio Lumipulse G Plasma Assays, Calibrators and Controls

Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging.

What happened

Fujirebio Diagnostics, Inc., of Malvern, Pennsylvania, recalled several Lumipulse G products, including calibrators, immunoreaction cartridges, controls, and a plasma ratio test, because customers may experience inaccurate test results.

The issue involves a higher frequency of classification in the indeterminate and positive zone and/or low specificity compared to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive or indeterminate ratio results, which could incorrectly classify a patient as having amyloid pathology associated with Alzheimer's disease or require more clinical testing.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

7 products

Match the UDI-DI, lot code and model/catalog number listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Lumipulse G pTau 217 Plasma Calibrators

    UDI-DI
    • 05414470815579
    Model/Catalog number
    • 81557
    Lot code
    • D5C6094U
    • D5C6125U
  2. Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio

    UDI-DI
    • 00869164000086
    Model/Catalog number
    • CL0073
  3. Lumipulse G pTau 217 Plasma Immunoreaction Cartridges

    UDI-DI
    • 05414470815500
    Model/Catalog number
    • 81550
    Lot code
    • D4C6028U
    • D4C6029U
    • D4C6051U
    • D4C6052U
  4. Lumipulse ¿-Amyloid Plasma Controls

    UDI-DI
    • 05414470815593
    Model/Catalog number
    • 81559
    Lot code
    • T8B6116U
  5. Lumipulse G ¿-Amyloid 1-42-N Plasma Immunoreaction Cartridges

    UDI-DI
    • 04987270235447
    Model/Catalog number
    • 235447
    Lot code
    • C5C6022U
    • C5C6045U
  6. Lumipulse pTau 217 Plasma Controls

    UDI-DI
    • 05414470815586
    Model/Catalog number
    • 81558
    Lot code
    • D6C6092U
    • D6C6092U1
    • D6C6123U
  7. Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators

    UDI-DI
    • 04987270235454
    Model/Catalog number
    • 235454
    Lot code
    • D8C6022U
    • D8C6044U

Recall details

Company began the recall
Sold in

US Nationwide distribution in the states of Arizona, California, Florida, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, Pennsylvania, Texas, Washington.

Company
Fujirebio Diagnostics, Inc.Malvern, Pennsylvania
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98232
Recall numbers
Z-1301-2026 to Z-1307-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)